Related references
Note: Only part of the references are listed.Dupilumab in prurigo nodularis: a systematic review of current evidence and analysis of predictive factors to response
Husein Husein-ElAhmed et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2022)
A New Era with the Development of Cytokine-Based Therapy for Pruritus
Rintaro Shibuya et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)
Major Risk Factors Analysis of Pruritus Complicated by Type 2 Diabetes Mellitus and the Effect of Comprehensive Nursing Intervention
Qiu Ping Yang et al.
FRONTIERS IN SURGERY (2022)
Itch intensity in prurigo nodularis is closely related to dermal interleukin-31, oncostatin M, IL-31 receptor alpha and oncostatin M receptor beta
Takashi Hashimoto et al.
EXPERIMENTAL DERMATOLOGY (2021)
Elevated interleukin 31 serum levels in hemodialysis patients are associated with uremic pruritus
Ashraf O. Oweis et al.
CYTOKINE (2021)
Itch in Adult Population with Type 2 Diabetes Mellitus: Clinical Profile, Pathogenesis and Disease-Related Burden in a Cross-Sectional Study
Aleksandra A. Stefaniak et al.
BIOLOGY-BASEL (2021)
Itch in diabetes: a common underestimated problem
Aleksandra A. Stefaniak et al.
POSTEPY DERMATOLOGII I ALERGOLOGII (2021)
Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4Rα antibody, is required to broadly inhibit type 2 inflammation
Audrey Le Floc'h et al.
ALLERGY (2020)
A systematic review on the functional role of Th1/Th2 cytokines in type 2 diabetes and related metabolic complications
Thabsile Mahlangu et al.
CYTOKINE (2020)
Epidemiology of Type 2 Diabetes - Global Burden of Disease and Forecasted Trends
Moien Abdul Basith Khan et al.
JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH (2020)
Neutrophils promote CXCR3-dependent itch in the development of atopic dermatitis
Carolyn M. Walsh et al.
ELIFE (2019)
European S2k Guideline on Chronic Pruritus In cooperation with the European Dermatology Forum (EDF) and the European Academy of Dermatology and Venereology (EADV)
Elke Weisshaar et al.
ACTA DERMATO-VENEREOLOGICA (2019)
Different expression patterns of plasma Th1-, Th2-, Th17-and Th22-related cytokines correlate with serum autoreactivity and allergen sensitivity in chronic spontaneous urticaria
Q. Chen et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Dupilumab: A review of its use in the treatment of atopic dermatitis
Melinda J. Gooderham et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis
M. Furue et al.
ALLERGY (2018)
Clinical Signs, Staphylococcus and Atopic Eczema-Related Seromarkers
Kam Lun Hon et al.
MOLECULES (2017)
12-Item Pruritus Severity Scale: Development and Validation of New Itch Severity Questionnaire
Adam Reich et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Cutaneous Manifestations of Diabetes Mellitus: A Review
Ana Luiza Lima et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2017)
CXCR3 chemokine receptor signaling mediates itch in experimental allergic contact dermatitis
Lintao Qu et al.
PAIN (2015)
Interferon gamma-induced protein 10 is associated with insulin resistance and incident diabetes in patients with nonalcoholic fatty liver disease
Chia-Chu Chang et al.
SCIENTIFIC REPORTS (2015)
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
Mark D. Turner et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)
Interleukin-31 is associated with uremic pruritus in patients receiving hemodialysis
Mei-Ju Ko et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
CXCL10 Activities, Biological Structure, and Source Along with Its Significant Role Played in Pathophysiology of Type I Diabetes Mellitus
Zahra Ahmadi et al.
INFLAMMATION (2013)
Analysis of Inflammatory Mediators in Type 2 Diabetes Patients
Ahmed Al-Shukaili et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2013)
Postprandial blood glucose is associated with generalized pruritus in patients with type 2 diabetes
Mei-Ju Ko et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2013)
Increased Levels of Serum Granulocyte-Macrophage Colony-Stimulating Factor Is Associated with Activated Peripheral Dendritic Cells in Type 2 Diabetes Subjects (CURES-99)
Jayagopi Surendar et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2012)
Pruritus in the elderly and its impact on quality of life
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Interleukin-2 serum levels are elevated in patients with uremic pruritus: a novel finding with practical implications
Mohammad Kazem Fallahzadeh et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
CXCL10 Impairs β Cell Function and Viability in Diabetes through TLR4 Signaling
Fabienne T. Schulthess et al.
CELL METABOLISM (2009)
The chemokine CXCL10 modulates excitatory activity and intracellular calcium signaling in cultured hippocampal neurons
TE Nelson et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
A second step of chemotaxis after transendothelial migration:: Keratinocytes undergoing apoptosis release IFN-γ-inducible protein 10, monokine induced by IFN-γ, and IFN-γ-inducible α-chemoattractant for T cell chemotaxis toward epidermis in atopic dermatitis
S Klunker et al.
JOURNAL OF IMMUNOLOGY (2003)
Dominant expression of CXCR3 is associated with induced expression of IP-10 at hapten-challenged sites of murine contact hypersensitivity:: a possible role for interferon-γ-producing CD8+ T cells in IP-10 expression
A Tokuriki et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2002)
CXCR3 expression and activation of eosinophils:: Role of IFN-γ-inducible protein-10 and monokine induced by IFN-γ
JQ Tan et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
